About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
The model reproduces the time profiles of PDL1 in a Neuroblastoma Cancer Cell, considering the activating mutation of ALK: ALKF1174L. We simulate the impact of two different therapy: Crizotinib and Ge.
Manifest
{
"io": {
"inputs": [
{
"name": "km_egf_source_parameter",
"label": "KmEGF source parameter",
"units": "native SBML value",
"default": 6086070,
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.km_egf_source_parameter",
"description": "KmEGF source parameter. Maps to bundled SBML parameter `KmEGF`."
},
{
"name": "kcat_egf_source_parameter",
"label": "KcatEGF source parameter",
"units": "native SBML value",
"default": 694.731,
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.kcat_egf_source_parameter",
"description": "KcatEGF source parameter. Maps to bundled SBML parameter `KcatEGF`."
},
{
"name": "initial_ngfr",
"label": "NGFR",
"units": "native SBML value",
"default": 14737,
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.initial_ngfr",
"description": "Initial NGFR. Sets the initial value of bundled SBML symbol `NGFR`."
},
{
"name": "initial_pip3",
"label": "PIP3",
"units": "native SBML value",
"default": 100000,
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.initial_pip3",
"description": "Initial PIP3. Sets the initial value of bundled SBML symbol `PIP3`."
},
{
"name": "initial_egfr_free",
"label": "EGFR free",
"units": "native SBML value",
"default": 618,
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.initial_egfr_free",
"description": "Initial EGFR free. Sets the initial value of bundled SBML symbol `EGFR_f`."
},
{
"name": "initial_sos_inactive",
"label": "SOS inactive",
"units": "native SBML value",
"default": 9456,
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.initial_sos_inactive",
"description": "Initial SOS inactive. Sets the initial value of bundled SBML symbol `SOS_inactive`."
}
],
"outputs": [
{
"name": "ngfr",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.ngfr",
"description": "NGFR observable. Maps to SBML symbol `NGFR`."
},
{
"name": "pip3",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.pip3",
"description": "PIP3 observable. Maps to SBML symbol `PIP3`."
},
{
"name": "egfr_free",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.egfr_free",
"description": "EGFR free observable. Maps to SBML symbol `EGFR_f`."
},
{
"name": "sos_inactive",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.sos_inactive",
"description": "SOS inactive observable. Maps to SBML symbol `SOS_inactive`."
},
{
"name": "p90_rsk_inactive",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.p90_rsk_inactive",
"description": "P90Rsk inactive observable. Maps to SBML symbol `P90Rsk_inactive`."
},
{
"name": "ras_inactive",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.ras_inactive",
"description": "RAS inactive observable. Maps to SBML symbol `RAS_inactive`."
},
{
"name": "state",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"systemsbiology",
"tumor-growth"
],
"title": "Lombardo2018 - Expression of PDL1 in Neuroblastoma Cancer Cell Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model_state"
],
"from": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.state"
},
{
"to": [
"visualisation.oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model_summary"
],
"from": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model_species_labels"
],
"from": "oncology_sbml_lombardo2018_expression_of_pdl1_in_neuroblastoma_model1812070002_model.species_labels"
}
],
"package": "lombardo2018-expression-of-pdl1-in-neuroblastoma-cancer-cell",
"runtime": {
"duration": 0.00575,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "The model reproduces the time profiles of PDL1 in a Neuroblastoma Cancer Cell, considering the activating mutation of ALK: ALKF1174L. We simulate the impact of two different therapy: Crizotinib and Ge.",
"schema_version": "2.0"
}Runtime
Duration0.00575
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packagelombardo2018-expression-of-pdl1-in-neuroblastoma-cancer-cell
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsystemsbiologytumor-growthvisualisationother